Yingying Tang - Publications

Affiliations: 
2014-2015 Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Harvard Medical School Shanghai Jio Tong University, China 

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Cho KIK, Zhang F, Penzel N, Seitz-Holland J, Tang Y, Zhang T, Xu L, Li H, Keshavan M, Whitfield-Gabrieli S, Niznikiewicz M, Stone WS, Wang J, Shenton ME, Pasternak O. Excessive interstitial free-water in cortical gray matter preceding accelerated volume changes in individuals at clinical high risk for psychosis. Molecular Psychiatry. PMID 38830974 DOI: 10.1038/s41380-024-02597-3  0.603
2024 Zhang T, Xu L, Wei Y, Cui H, Tang X, Hu Y, Tang Y, Wang Z, Liu H, Chen T, Li C, Wang J. Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP Study. Schizophrenia Bulletin. PMID 38741342 DOI: 10.1093/schbul/sbae066  0.39
2024 Zhang T, Cui H, Tang X, Xu L, Wei Y, Hu Y, Tang Y, Wang Z, Liu H, Chen T, Li C, Wang J. Models of mild cognitive deficits in risk assessment in early psychosis. Psychological Medicine. 1-12. PMID 38433595 DOI: 10.1017/S0033291724000382  0.33
2023 Zhang T, Xu L, Tang X, Wei Y, Hu Y, Cui H, Tang Y, Li C, Wang J. Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification. Pcn Reports : Psychiatry and Clinical Neurosciences. 2: e152. PMID 38868725 DOI: 10.1002/pcn5.152  0.42
2023 Jiang Y, Luo C, Wang J, Palaniyappan L, Chang X, Xiang S, Zhang J, Duan M, Huang H, Gaser C, Nemoto K, Miura K, Hashimoto R, Westlye LT, Richard G, ... ... Tang Y, et al. Two neurostructural subtypes: results of machine learning on brain images from 4,291 individuals with schizophrenia. Medrxiv : the Preprint Server For Health Sciences. PMID 37873296 DOI: 10.1101/2023.10.11.23296862  0.315
2023 Cho KI, Pasternak O, Zhang F, Penzel N, Seitz-Holland J, Tang Y, Zhang T, Xu L, Li H, Keshavan M, Whitfield-Gabrielli S, Niznikiewicz M, Stone W, Wang J, Shenton M. Microstructural Cortical Gray Matter Changes Preceding Accelerated Volume Changes in Individuals at Clinical High Risk for Psychosis. Research Square. PMID 37841868 DOI: 10.21203/rs.3.rs-3179575/v1  0.621
2023 Zhang T, Xu L, Wei Y, Tang X, Hu Y, Cui H, Tang Y, Wang Z, Liu H, Chen T, Li C, Wang J. Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis. Psychiatry Research. 329: 115522. PMID 37812943 DOI: 10.1016/j.psychres.2023.115522  0.328
2023 Tang Y, Xu L, Zhu T, Cui H, Qian Z, Kong G, Tang X, Wei Y, Zhang T, Hu Y, Sheng J, Wang J. Visuospatial Learning Selectively Enhanced by Personalized Transcranial Magnetic Stimulation over Parieto-Hippocampal Network among Patients at Clinical High-Risk for Psychosis. Schizophrenia Bulletin. PMID 36841956 DOI: 10.1093/schbul/sbad015  0.342
2022 Zhang T, Wei Y, Zeng J, Ye J, Tang X, Xu L, Hu Y, Cui H, Tang Y, Wang J. Interleukin-2/Interleukin-6 Imbalance Correlates with Conversion to Psychosis from a Clinical High-Risk State. Psychiatry and Clinical Neurosciences. PMID 36097689 DOI: 10.1111/pcn.13476  0.35
2022 Xu L, Cui H, Wei Y, Qian Z, Tang X, Hu Y, Wang Y, Hu H, Guo Q, Tang Y, Zhang T, Wang J. Relationships between self-reflectiveness and clinical symptoms in individuals during pre-morbid and early clinical stages of psychosis. General Psychiatry. 35: e100696. PMID 35721834 DOI: 10.1136/gpsych-2021-100696  0.309
2022 Hu Y, Wu J, Cao Y, Tang X, Wu G, Guo Q, Xu L, Qian Z, Wei Y, Tang Y, Li C, Zhang T, Wang J. Abnormal neural oscillations in clinical high risk for psychosis: a magnetoencephalography method study. General Psychiatry. 35: e100712. PMID 35572772 DOI: 10.1136/gpsych-2021-100712  0.36
2022 Zeng J, Raballo A, Gan R, Wu G, Wei Y, Xu L, Tang X, Hu Y, Tang Y, Chen T, Li C, Wang J, Zhang T. Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study. The Journal of Clinical Psychiatry. 83. PMID 35324095 DOI: 10.4088/JCP.21m14092  0.413
2022 Xu L, Zhang M, Wang S, Wei Y, Cui H, Qian Z, Wang Y, Tang X, Hu Y, Tang Y, Zhang T, Wang J. Corrigendum: Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals. Frontiers in Psychiatry. 13: 839315. PMID 35211047 DOI: 10.3389/fpsyt.2022.839315  0.321
2022 Su W, Yuan A, Tang Y, Xu L, Wei Y, Wang Y, Li Z, Cui H, Qian Z, Tang X, Hu Y, Zhang T, Feng J, Li Z, Zhang J, et al. Effects of polygenic risk of schizophrenia on interhemispheric callosal white matter integrity and frontotemporal functional connectivity in first-episode schizophrenia. Psychological Medicine. 1-10. PMID 34991756 DOI: 10.1017/S0033291721004840  0.377
2022 Chen S, Tang Y, Fan X, Qiao Y, Wang J, Wen H, Wang W, Wang H, Yang F, Sheng J. The role of white matter abnormality in the left anterior corona radiata: In relation to formal thought disorder in patients with schizophrenia. Psychiatry Research. 307: 114302. PMID 34890908 DOI: 10.1016/j.psychres.2021.114302  0.335
2021 Li Z, Zhang T, Xu L, Wei Y, Cui H, Tang Y, Liu X, Qian Z, Zhang H, Liu P, Li C, Wang J. Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis. Schizophrenia Research. 239: 19-28. PMID 34800912 DOI: 10.1016/j.schres.2021.11.011  0.369
2021 Zhang T, Wang J, Xu L, Wei Y, Tang X, Hu Y, Cui H, Tang Y, Li C, Ling Z, Wang J. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals. European Archives of Psychiatry and Clinical Neuroscience. PMID 34536114 DOI: 10.1007/s00406-021-01331-2  0.386
2021 Wang Y, Jiang Y, Collin G, Liu D, Su W, Xu L, Wei Y, Tang Y, Zhang T, Tang X, Hu Y, Zhang J, Cui H, Wang J, Yao D, et al. The effects of antipsychotics on interactions of dynamic functional connectivity in the triple-network in first episode schizophrenia. Schizophrenia Research. 236: 29-37. PMID 34365083 DOI: 10.1016/j.schres.2021.07.038  0.661
2021 Liu Z, Palaniyappan L, Wu X, Zhang K, Du J, Zhao Q, Xie C, Tang Y, Su W, Wei Y, Xue K, Han S, Tsai SJ, Lin CP, Cheng J, et al. Resolving heterogeneity in schizophrenia through a novel systems approach to brain structure: individualized structural covariance network analysis. Molecular Psychiatry. PMID 34316005 DOI: 10.1038/s41380-021-01229-4  0.339
2021 Zhang T, Cui H, Wei Y, Tang X, Xu L, Hu Y, Tang Y, Chen T, Li C, Wang J. Neurocognitive assessments are more important among adolescents than adults for predicting psychosis in clinical high risk. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34274517 DOI: 10.1016/j.bpsc.2021.06.015  0.35
2021 Anteraper SA, Guell X, Collin G, Qi Z, Ren J, Nair A, Seidman LJ, Keshavan MS, Zhang T, Tang Y, Li H, McCarley RW, Niznikiewicz MA, Shenton ME, Stone WS, et al. Abnormal Function in Dentate Nuclei Precedes the Onset of Psychosis: A Resting-State fMRI Study in High-Risk Individuals. Schizophrenia Bulletin. PMID 33954497 DOI: 10.1093/schbul/sbab038  0.746
2021 Zhang T, Xu L, Li H, Cui H, Tang Y, Wei Y, Tang X, Hu Y, Hui L, Li C, Niznikiewicz MA, Shenton ME, Keshavan MS, Stone WS, Wang J. Individualized risk components guiding antipsychotic delivery in patients with a clinical high risk of psychosis: application of a risk calculator. Psychological Medicine. 1-10. PMID 33593473 DOI: 10.1017/S0033291721000064  0.653
2020 Zhang F, Cho KIK, Tang Y, Zhang T, Kelly S, Biase MD, Xu L, Li H, Matcheri K, Whitfield-Gabrieli S, Niznikiewicz M, Stone WS, Wang J, Shenton ME, Pasternak O. MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis. Neuroimage. 117564. PMID 33285331 DOI: 10.1016/j.neuroimage.2020.117564  0.715
2020 Zhang T, Wang J, Xu L, Wei Y, Tang X, Hu Y, Cui H, Tang Y, Hui L, Li C, Wang J. Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission. Pharmacopsychiatry. PMID 33045753 DOI: 10.1055/a-1252-2942  0.349
2020 Cui H, Giuliano AJ, Zhang T, Xu L, Wei Y, Tang Y, Qian Z, Stone LM, Li H, Whitfield-Gabrieli S, Niznikiewicz M, Keshavan MS, Shenton ME, Wang J, Stone WS. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes. Schizophrenia Research. PMID 32694037 DOI: 10.1016/j.schres.2020.06.018  0.649
2020 Zhang T, Xu L, Tang X, Wei Y, Hu Q, Hu Y, Cui H, Tang Y, Hui L, Li C, Cao L, Lu Z, Wang J. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis). The Australian and New Zealand Journal of Psychiatry. 4867420917449. PMID 32436725 DOI: 10.1177/0004867420917449  0.417
2020 Collin G, Nieto-Castanon A, Shenton M, Pasternak O, Kelly S, Keshavan M, Seidman L, McCarley R, Niznikiewicz M, Li H, Zhang T, Tang Y, Stone W, Wang J, Whitfield-Gabrieli S. S147. Functional Brain Connectivity Data Improve Clinical Outcome Prediction In Youth At Risk For Psychosis Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.213  0.768
2019 Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T. Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2). Neuropsychiatric Disease and Treatment. 15: 3541-3548. PMID 31920314 DOI: 10.2147/NDT.S230904  0.37
2019 Zhang T, Xu L, Li H, Woodberry KA, Kline ER, Jiang J, Cui H, Tang Y, Tang X, Wei Y, Hui L, Lu Z, Cao L, Li C, Niznikiewicz MA, et al. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program. Psychological Medicine. 1-8. PMID 31839016 DOI: 10.1017/S003329171900360X  0.645
2019 Collin G, Nieto-Castanon A, Shenton ME, Pasternak O, Kelly S, Keshavan MS, Seidman LJ, McCarley RW, Niznikiewicz MA, Li H, Zhang T, Tang Y, Stone WS, Wang J, Whitfield-Gabrieli S. Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis. Neuroimage. Clinical. 102108. PMID 31791912 DOI: 10.1016/J.Nicl.2019.102108  0.766
2019 Zhang T, Tang X, Li H, Woodberry KA, Kline ER, Xu L, Cui H, Tang Y, Wei Y, Li C, Hui L, Niznikiewicz MA, Shenton ME, Keshavan MS, Stone WS, et al. Clinical subtypes that predict conversion to psychosis: A canonical correlation analysis study from the ShangHai At Risk for Psychosis program. The Australian and New Zealand Journal of Psychiatry. 4867419872248. PMID 31486343 DOI: 10.1177/0004867419872248  0.662
2019 Zhang T, Yang S, Xu L, Tang X, Wei Y, Cui H, Li H, Tang Y, Hui L, Li C, Chen X, Wang J. Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP. Psychological Medicine. 1-7. PMID 31451124 DOI: 10.1017/S0033291719002174  0.419
2019 Tang Y, Pasternak O, Kubicki M, Rathi Y, Zhang T, Wang J, Li H, Woodberry KA, Xu L, Qian Z, Zhu A, Whitfield-Gabrieli S, Keshavan MS, Niznikiewicz M, Stone WS, et al. Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis. The American Journal of Psychiatry. appiajp201918091044. PMID 31230461 DOI: 10.1176/Appi.Ajp.2019.18091044  0.728
2019 Tang Y, Wang J, Zhang T, Xu L, Qian Z, Cui H, Tang X, Li H, Whitfield-Gabrieli S, Shenton ME, Seidman LJ, McCarley RW, Keshavan MS, Stone WS, Wang J, et al. P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature. Schizophrenia Research. PMID 30819593 DOI: 10.1016/J.Schres.2019.02.014  0.577
2019 Wei Y, Zhang T, Xu L, Tang Y, Wang J. S69. NEURAL-SYNCHRONIZATION DURING COOPERATION TASK IN CLINICAL HIGH RISK OF PSYCHOSIS-A FNIRS-BASED HYPERSCANNING STUDY Schizophrenia Bulletin. 45: S333-S333. DOI: 10.1093/SCHBUL/SBZ020.614  0.313
2019 Xu L, Zhang T, Tang Y, Cui H, Wei Y, Tang X, Wang J. S10. IMPAIRMENT OF REALITY TESTING IN INDIVIDUALS AT CLINICAL HIGH-RISK OF PSYCHOSIS Schizophrenia Bulletin. 45: S309-S310. DOI: 10.1093/SCHBUL/SBZ020.555  0.361
2018 Kong L, Cui H, Zhang T, Wang Y, Huang J, Zhu Y, Tang Y, Herold CJ, Schröder J, Cheung EFC, Chan RCK, Wang J. Neurological soft signs and grey matter abnormalities in individuals with ultra-high risk for psychosis. Psych Journal. PMID 30515993 DOI: 10.1002/Pchj.258  0.374
2018 Collin G, Seidman LJ, Keshavan MS, Stone WS, Qi Z, Zhang T, Tang Y, Li H, Anteraper SA, Niznikiewicz MA, McCarley RW, Shenton ME, Wang J, Whitfield-Gabrieli S. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program. Molecular Psychiatry. PMID 30410064 DOI: 10.1038/S41380-018-0288-X  0.783
2018 Zhang T, Xu L, Tang Y, Cui H, Wei Y, Tang X, Hu Q, Wang Y, Zhu Y, Jiang L, Hui L, Liu X, Li C, Wang J. Isolated hallucination is less predictive than thought disorder in psychosis: Insight from a longitudinal study in a clinical population at high risk for psychosis. Scientific Reports. 8: 13962. PMID 30228293 DOI: 10.1038/s41598-018-32215-6  0.322
2018 Zhang T, Xu L, Tang Y, Li H, Tang X, Cui H, Wei Y, Wang Y, Hu Q, Liu X, Li C, Lu Z, McCarley RW, Seidman LJ, Wang J, et al. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator. Psychological Medicine. 1-9. PMID 30213278 DOI: 10.1017/S0033291718002738  0.383
2018 Zhang T, Li H, Tang Y, Niznikiewicz MA, Shenton ME, Keshavan MS, Stone WS, McCarley RW, Seidman LJ, Wang J. Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program. The American Journal of Psychiatry. 175: 906-908. PMID 30173545 DOI: 10.1093/Schbul/Sby018.892  0.642
2018 Zhang T, Li H, Xu L, Tang Y, Cui H, Wang J, Li C, Woodberry K, Shapiro DI, Niznikiewicz M, Shenton ME, Keshavan MS, Stone WS, Wang J, McCarley RW, et al. S105. VALIDATING THE PREDICTIVE ACCURACY OF THE NAPLS-2 PSYCHOSIS RISK CALCULATOR IN A CLINICAL HIGH-RISK SAMPLE FROM THE SHARP (SHANGHAI AT RISK FOR PSYCHOSIS) PROGRAM Schizophrenia Bulletin. 44: S366-S366. DOI: 10.1093/schbul/sby018.892  0.641
2018 Collin G, Seidman L, Keshavan MS, Qi Z, Stone WS, Zhang T, Tang Y, Shenton ME, Wang J, Whitfield-Gabrieli S. O10.5. Abnormal Modular Organization Of The Functional Connectome Predicts Conversion To Psychosis In Clinical High-Risk Youth Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby015.257  0.756
2018 Zhang T, Li H, Tang Y, Li C, Woodberry K, Shapiro DI, Niznikiewicz M, Shenton ME, Keshavan MS, Stone WS, Wang J. 21.4 BASELINE CLINICAL AND BIOLOGICAL VARIABLES PREDICTING 1 YEAR OUTCOME OF SUBJECTS AT CLINICAL HIGH RISK OF PSYCHOSIS: INSIGHT FROM SHANGHAI AT RISK FOR PSYCHOSIS (SHARP) PROGRAM Schizophrenia Bulletin. 44: S36-S36. DOI: 10.1093/Schbul/Sby014.088  0.66
2018 del Re EC, Stone W, Bouix S, Somes N, Tang Y, TianHong Z, Whitfield-Gabrieli S, Wang J, Seidman L, Keshavan M, Niznikiewicz M, Makris N, McCarley R, Shenton M. F225. Structural and Tractography Analysis of Clinical High Risk Subjects for Psychosis From the Sharp Study Cohort Biological Psychiatry. 83: S326. DOI: 10.1016/J.Biopsych.2018.02.839  0.598
2017 Li H, Zhang T, Xu L, Tang Y, Cui H, Wei Y, Tang X, Woodberry KA, Shapiro DI, Li C, Seidman LJ, Wang J. A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China. Schizophrenia Research. PMID 29287626 DOI: 10.1016/J.Schres.2017.11.029  0.323
2017 Zhang T, Xu L, Tang Y, Cui H, Wei Y, Wang J, Tang X, Li C, Wang J. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome. Psychological Medicine. 1-8. PMID 29173206 DOI: 10.1017/S0033291717002707  0.347
2017 Zhang T, Xu L, Tang Y, Cui H, Li H, Wei Y, Xu Y, Jiang L, Zhu Y, Li C, Jiang K, Xiao Z, Wang J. Using 'WeChat' online social networking in a real-world needs analysis of family members of youths at clinical high risk of psychosis. The Australian and New Zealand Journal of Psychiatry. 4867417712460. PMID 28587479 DOI: 10.1177/0004867417712460  0.353
2017 Zhang T, Li H, Xu L, Tang Y, Cui H, Wei Y, Woodberry KA, Shapiro DI, Stone WS, Seidman LJ, Wang J. SU39. Do Baseline Clinical and Neurocognitive Features Predict Conversion in Individuals With Clinical High Risk to Psychosis in Shanghai? Schizophrenia Bulletin. 43: S175-S175. DOI: 10.1093/Schbul/Sbx024.037  0.4
2017 Wang J, Tang Y, Pasternak O, Kubicki M, Rathi Y, Zhang T, Wang J, Li H, Woodberry K, Xu L, Qian Z, Zhu A, Whitfield-Gabrieli S, McCarley R, Shenton M, ... ... Tang Y, et al. 13. The Extents of Extracellular and Brain Tissue Related Abnormalities in Subjects at Clinical High Risk of Psychosis Schizophrenia Bulletin. 43: S11-S12. DOI: 10.1093/Schbul/Sbx021.032  0.704
2016 Kikinis Z, Cho KI, Coman IL, Radoeva PD, Bouix S, Tang Y, Eckbo R, Makris N, Kwon JS, Kubicki M, Antshel KM, Fremont W, Shenton ME, Kates WR. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms. Brain Imaging and Behavior. PMID 27730479 DOI: 10.1007/S11682-016-9602-X  0.743
2016 Zhang T, Tang Y, Cui H, Lu X, Xu L, Liu X, Li H, Chow A, Du Y, Li C, Jiang K, Xiao Z, Wang J. Theory of Mind Impairments in Youth at Clinical High Risk of Psychosis. Psychiatry. 79: 40-55. PMID 27187512 DOI: 10.1080/00332747.2015.1123592  0.342
Show low-probability matches.